Yep

Yep is a company that develops treatments for eye diseases, such as its vision treatment studied in a recent clinical trial.

Why it’s in the news: It is in the news due to the disappointing results of a study for its vision treatment.

Latest on Yep

• STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
• STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
• Yep, we’re using OpenClaw to date now

Connections

1 entities linked to Yep across the news graph.